Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health cash
Cash and short-term investments held at the end of each period.
Evolent Health's cash was $148.26M at Sep 30, 2026. For fiscal 2025 it was $151.86M, down 14.9% from the year before. Over ten years it grew -0.6% a year on average. The highest annual figure on record is $388.33M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $151.86M | -14.9% |
| FY2024 | Dec 31, 2024 | $178.50M | -20.1% |
| FY2023 | Dec 31, 2023 | $223.46M | +3.9% |
| FY2022 | Dec 31, 2022 | $215.16M | -39.4% |
| FY2021 | Dec 31, 2021 | $354.94M | -1.8% |
| FY2020 | Dec 31, 2020 | $361.58M | +181.3% |
| FY2019 | Dec 31, 2019 | $128.53M | -66.9% |
| FY2018 | Dec 31, 2018 | $388.33M | +31.5% |
| FY2017 | Dec 31, 2017 | $295.36M | +37.8% |
| FY2016 | Dec 31, 2016 | $214.37M | +32.8% |
| FY2015 | Dec 31, 2015 | $161.46M | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $5.25M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $148.26M | +27.1% |
| Q2 FY2026 | Jun 30, 2026 | $115.70M | -23.4% |
| Q1 FY2026 | Mar 31, 2026 | $142.03M | -42.4% |
| Q4 FY2025 | Dec 31, 2025 | $151.86M | -14.9% |
| Q3 FY2025 | Sep 30, 2025 | $116.65M | +20.8% |
| Q2 FY2025 | Jun 30, 2025 | $151.00M | +49.1% |
| Q1 FY2025 | Mar 31, 2025 | $246.55M | +49.3% |
| Q4 FY2024 | Dec 31, 2024 | $178.50M | -20.1% |
| Q3 FY2024 | Sep 30, 2024 | $96.58M | -47.7% |
| Q2 FY2024 | Jun 30, 2024 | $101.25M | -29.0% |
| Q1 FY2024 | Mar 31, 2024 | $165.15M | +4.8% |
| Q4 FY2023 | Dec 31, 2023 | $223.46M | +3.9% |
| Q3 FY2023 | Sep 30, 2023 | $184.54M | +17.7% |
| Q2 FY2023 | Jun 30, 2023 | $142.53M | -26.2% |
| Q1 FY2023 | Mar 31, 2023 | $157.52M | -25.0% |
| Q4 FY2022 | Dec 31, 2022 | $215.16M | -39.4% |
| Q3 FY2022 | Sep 30, 2022 | $156.76M | -44.4% |
| Q2 FY2022 | Jun 30, 2022 | $193.07M | -19.0% |
| Q1 FY2022 | Mar 31, 2022 | $210.16M | -30.8% |
| Q4 FY2021 | Dec 31, 2021 | $354.94M | -1.8% |
| Q3 FY2021 | Sep 30, 2021 | $281.76M | -24.0% |
| Q2 FY2021 | Jun 30, 2021 | $238.41M | +142.6% |
| Q1 FY2021 | Mar 31, 2021 | $303.77M | +347.1% |
| Q4 FY2020 | Dec 31, 2020 | $361.58M | +181.3% |
| Q3 FY2020 | Sep 30, 2020 | $370.51M | +80.0% |
| Q2 FY2020 | Jun 30, 2020 | $98.27M | -28.4% |
| Q1 FY2020 | Mar 31, 2020 | $67.94M | -70.1% |
| Q4 FY2019 | Dec 31, 2019 | $128.53M | -66.9% |
| Q3 FY2019 | Sep 30, 2019 | $205.80M | -22.9% |
| Q2 FY2019 | Jun 30, 2019 | $137.20M | -46.0% |
| Q1 FY2019 | Mar 31, 2019 | $227.50M | -3.8% |
| Q4 FY2018 | Dec 31, 2018 | $388.33M | +31.5% |
| Q3 FY2018 | Sep 30, 2018 | $266.80M | -9.8% |
| Q2 FY2018 | Jun 30, 2018 | $254.30M | +123.2% |
| Q1 FY2018 | Mar 31, 2018 | $236.40M | +71.3% |
| Q4 FY2017 | Dec 31, 2017 | $295.36M | +37.8% |
| Q3 FY2017 | Sep 30, 2017 | $295.90M | – |
| Q2 FY2017 | Jun 30, 2017 | $113.94M | – |
| Q1 FY2017 | Mar 31, 2017 | $137.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $214.37M | – |
See a number that looks wrong?